EL PASO, TX / ACCESS Newswire / September 3, 2025 / Viva Capital Funding, LLC (Viva), a leading invoice factoring specialty finance company, announced the successful upsizing of their investment-grade corporate notes to $30.5 million. Since 2018, Viva has provided over $2B in capital to growing companies across a variety of industries throughout the U.S. Proceeds will be used by the Company to support additional growth of the business.
“We are pleased to have completed this note financing with a committed group of investors,” said Viva’s President, Greg DiDonna. “Their participation demonstrates belief in our business strategy and growth prospects, providing us with the resources needed to capitalize on the market opportunities ahead of us.”
Michael Marshall, Director of Finance at Viva, added, “This funding represents a significant step forward in executing our long-term objectives. The capital will strengthen our balance sheet and provide the financial flexibility to make critical investments in our technology infrastructure and new lines of business.”
Brean Capital, LLC served as the Company’s exclusive financial advisor and sole placement agent in connection with the transaction.
About Viva Capital Funding, LLC:
Founded in 1999, Viva Capital Funding, LLC is a specialty finance company providing simple, fast and reliable financing solutions across a diverse range of industries throughout the United States. Headquartered in El Paso, TX, the Company offers factoring, reverse factoring and land banking services while maintaining the highest standard of performance, ethics and integrity. For additional information about the company, please visit: http://www.vivacf.net.
Contact Information
Armando Armendariz
Director of Business Development
factoring@vivacf.net
915-615-6664
SOURCE: Viva Capital Funding, LLC
View the original press release on ACCESS Newswire
BUENOS AIRES, ARGENTINA, MARCH 31, 2026 ― When the Teatro Colón opens its doors to…
Creative Technology Group, Inc. (CT), the NEP Live Events group, has invested in multiple Analog…
AiGS will leverage n8n's platform to deliver future-ready automation solutions that streamline operations and unlock…
First-in-class metal-modulating epigenetic therapy targeting iron-dependent pathways with preclinical efficacy and a favorable GLP safety…
PHOENIX, AZ / ACCESS Newswire / March 31, 2026 / 1606 Corp. (OTCID:CBDW) ("1606" or…
Company Invites Investors to Submit Questions to be Answered on the Webcasted Earnings Call TORONTO,…